谷歌浏览器插件
订阅小程序
在清言上使用

Constitutive Single Nucleotide Polymorphisms (SNP) Assessment for Predicting Tolerability and Efficacy of Triplet Hepatic Artery Infusion (HAI) and Intravenous Cetuximab (IV-CET) in Patients (pts) with Liver Metastases from Colorectal Cancer (LM-CRC) (european Trial OPTILIV, NCT00852228).

Journal of Clinical Oncology(2014)

引用 0|浏览33
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要